CHEMOTHERAPY OF CHRONIC LYMPHOCYTIC LEUKEMIA

被引:11
作者
KAUNG, DT
WHITTINGTON, RM
PATNO, ME
机构
关键词
D O I
10.1001/archinte.1964.03860100103011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:521 / +
页数:1
相关论文
共 26 条
[1]  
ALTMAN SJ, 1956, CANCER, V9, P512, DOI 10.1002/1097-0142(195605/06)9:3<512::AID-CNCR2820090312>3.0.CO
[2]  
2-O
[3]  
BIGLEY RH, 1963, CANCER CHEMOTH REP, P27
[4]   EVALUATION OF CB-1348 IN HODGKINS DISEASE AND ALLIED DISORDERS [J].
BOURONCLE, BA ;
DOAN, CA ;
WISEMAN, BK ;
FRAJOLA, WJ .
ARCHIVES OF INTERNAL MEDICINE, 1956, 97 (06) :703-714
[5]  
BRICHTA G, 1958, Wien Z Inn Med, V39, P306
[6]   CLINICAL EVALUATION OF CB-1348 IN LEUKEMIAS AND LYMPHOMAS [J].
DOAN, CA ;
WISEMAN, BK ;
BOURONCLE, BA .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1958, 68 (03) :979-995
[7]   CLINICAL TRIALS OF PARA-(DI-2-CHLOROETHYLAMINO)-PHENYLBUTYRIC ACID (CB 1348) IN MALIGNANT LYMPHOMA [J].
GALTON, DAG ;
ISRAELS, LG ;
NABARRO, JDN ;
TILL, M .
BRITISH MEDICAL JOURNAL, 1955, 2 (NOV12) :1172-1176
[8]  
GALTON DAG, 1960, LECTURES HEMATOLOGY, P158
[9]   PRELIMINARY RESULTS OF THE TREATMENT OF MALIGNANT TUMOURS WITH A NEW NITROGEN MUSTARD DERIVATIVE [J].
GROSS, R ;
LAMBERS, K .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1958, 83 (12) :458-462
[10]  
HAAR H, 1960, CANCER CHEMOTH REP, P41